Skip to main content

Find Clinical Trials

Home
Conditions
IgA Nephropathy (IgAN)

Clinical trial condition

IgA Nephropathy (IgAN)

Explore clinical trials studying IgA Nephropathy (IgAN). Study availability and eligibility vary by location and protocol.

32 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

IgA Nephropathy (IgAN) trial results

Active, Not Recruiting

Monthly Dosing of Atacicept in IgAN

NCT07020923

Conditions: Autoimmune Diseases, Berger Disease, Female Urogenital Diseases, +10 more
Locations: Vera Therapeutics Brisbane, California, United States

View Trial Details

Active, Not Recruiting

To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

NCT07098897

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: The First Affiliated hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details